Physician profile
Huma Khan
NPI 1396960506
$1,127.40
in general payments reported to CMS, 2019-2025
17 companies · $685 in 2025
The $685 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $102 · 2024: $340 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $154.50 | 2024-2025 | Veozah |
| Lilly USA, LLC | $137.19 | 2025 | Mounjaro, Kisunla |
| Glaxosmithkline, LLC. | $136.32 | 2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Novo Nordisk INC | $129.34 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $116.51 | 2024-2025 | Saphnelo, Breztri |
| Ani Pharmaceuticals, INC. | $104.10 | 2024 | Purified Cortrophin Gel |
| Bayer Healthcare Pharmaceuticals INC. | $69.89 | 2025 | |
| Abbvie INC. | $63.22 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $60.19 | 2025 | |
| Fresenius Kabi USA, LLC | $25.42 | 2024 | Idacio |
| Coopersurgical, INC. | $23.31 | 2024 | Paragard T 380a |
| Omeza LLC | $22.93 | 2024 | |
| Ucb, INC. | $22.76 | 2025 | Bimzelx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.32 | 2023 | Jardiance |
| Organon LLC | $15.53 | 2023 | Nexplanon |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.20 | 2025 | |
| Exact Sciences Corporation | $13.67 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Huma Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.